Dec 19 (Reuters) - BioMarin Pharmaceutical (BMRN) said on Friday it would acquire Amicus Therapeutics (FOLD) for about $4.8 billion, expanding its presence in rare metabolic diseases.
The drugmaker will pay $14.50 per share for Amicus, a premium of 33.1% to the stock's last close. Shares of Amicus surged 30%, while BioMarin rose nearly 5% in premarket trading.
The deal strengthens BioMarin's portfolio with Amicus' approved genetic disorder treatments including Galafold, an oral drug for Fabry disease, which is caused by a faulty gene that leads to a buildup of fatty substances in cells.
Amicus also markets a combination therapy Pombiliti and Opfolda for Pompe disease, a genetic condition in which a complex sugar called glycogen builds up in the body's cells.
Amicus also has U.S. rights to DMX-200, a potential treatment of a type of kidney disease known as focal segmental glomerulosclerosis.
BioMarin intends to finance the deal through a combination of cash on hand and about $3.7 billion of non-convertible debt financing.
The company's total cash and investments at the end of September 30 were about $2 billion.
The acquisition, which is expected to close in the second quarter of 2026, will add revenue immediately after the transaction closes, BioMarin said.
The deal is also expected to add to adjusted profit in the first 12 months after close and be substantially accretive beginning in 2027, the company said.
(Reporting by Christy Santhosh and Sriparna Roy in Bengaluru; Editing by Leroy Leo and Maju Samuel)
LATEST POSTS
- 1
NASA's Voyager 1 set to achieve historic distance from Earth - 2Moon rush: These private spacecraft will attempt lunar landings in 2026
- 3Famous Restroom Beautifying Styles For 2024
- 4Find the Advantages of Careful Eating: Developing a Sound Connection with Food
- 5The Best Web-based Courses for Expertise Improvement
- Study shows no clear link between low-fat dairy and dementia risk
- Key Training: Picking a Significant for Monetary Achievement
- The Most Notable Design Brands of the 21st Hundred years
- Judge sets $60K bond for Florida congresswoman accused of stealing $5M in COVID-19 funds
- How a niche Catholic approach to infertility treatment became a new talking point for MAHA conservatives
- Surveys of Thrillers That Re-imagined the Class
- Birds at a college changed beak shapes during the pandemic. It might be a case of rapid evolution
- Sea Ice Hits New Low in Hottest Year on Record for the Arctic
- Everything you should know before booking a trip to Spain
